H Goto Selected Research

Antigens

6/2017	Core I97L mutation in conjunction with P79Q is associated with persistent low HBV DNA and HBs antigen clearance in patients with chronic hepatitis B.
7/2011	Dynamics of immunosuppression in hamsters with experimental visceral leishmaniasis.
2/2009	Unusual manifestations of tegumentary leishmaniasis in AIDS patients from the New World.
11/2004	Leishmania infantum heat shock protein 83 for the serodiagnosis of tegumentary leishmaniasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H Goto Research Topics

Disease

12	Infections 03/2016 - 08/2000
12	Neoplasms (Cancer) 10/2015 - 05/2000
5	Hemorrhage 04/2016 - 01/2000
4	Wounds and Injuries (Trauma) 09/2014 - 11/2000
4	Leishmaniasis 07/2013 - 04/2004
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017 - 02/2007
3	Visceral Leishmaniasis (Kala Azar) 07/2011 - 04/2001
3	Carcinoma (Carcinomatosis) 09/2008 - 07/2002
3	Rheumatoid Arthritis 01/2008 - 03/2000
3	Gastritis 06/2007 - 12/2001
3	Shock 03/2004 - 07/2000
3	Hypotension (Low Blood Pressure) 10/2001 - 04/2000
3	Renal Cell Carcinoma (Grawitz Tumor) 06/2001 - 02/2000
2	Liver Cirrhosis (Hepatic Cirrhosis) 06/2018 - 09/2008
2	Pathologic Constriction (Stenosis) 10/2015 - 10/2004
2	Carcinogenesis 10/2013 - 02/2007
2	Ulcerative Colitis 10/2009 - 12/2006
2	Cutaneous Leishmaniasis 08/2007 - 08/2000
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2007 - 12/2006
2	Glomerulonephritis 06/2007 - 04/2001
2	Atrophy 02/2007 - 02/2006
2	Inflammation (Inflammations) 12/2006 - 08/2000
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2006 - 09/2002
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2005 - 01/2000
2	Vascular System Injuries 02/2004 - 03/2002
2	Body Weight (Weight, Body) 02/2004 - 03/2002
2	Cysts 07/2002 - 05/2000
2	Hypertension (High Blood Pressure) 07/2002 - 10/2001
2	Melanoma (Melanoma, Malignant) 12/2001 - 09/2001
2	Uveal melanoma 12/2001 - 09/2001
2	Leukemia 06/2001 - 10/2000
2	Pain (Aches) 05/2001 - 01/2001
2	Atherosclerosis 01/2001 - 11/2000
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2000 - 10/2000
2	Neuroblastoma 12/2000 - 10/2000
2	Fever (Fevers) 10/2000 - 01/2000
1	Mastitis 05/2020
1	Lung Diseases (Lung Disease) 06/2018
1	Hepatitis 06/2017
1	Chronic Hepatitis B 06/2017
1	Fibrosis (Cirrhosis) 06/2017
1	Adenocarcinoma of Lung 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2017
1	Primary Effusion Lymphoma 01/2017
1	Hepatic Encephalopathy 11/2015

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 01/2015 - 01/2000
7	Proteins (Proteins, Gene)FDA Link 01/2017 - 06/2000
4	DNA (Deoxyribonucleic Acid)IBA 06/2017 - 03/2000
4	AntigensIBA 06/2017 - 11/2004
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2004 - 01/2001
4	Lipid PeroxidesIBA 02/2004 - 01/2001
3	VaccinesIBA 05/2020 - 11/2001
3	AntibodiesIBA 05/2020 - 10/2000
3	Biomarkers (Surrogate Marker)IBA 06/2018 - 05/2001
3	InterferonsIBA 01/2017 - 04/2004
3	Pharmaceutical PreparationsIBA 09/2014 - 08/2001
3	Insulin-Like Growth Factor I (IGF-1)IBA 07/2013 - 08/2000
3	Insulin-Like PeptidesIBA 07/2013 - 08/2000
3	Capsules (Microcapsules)IBA 01/2013 - 01/2006
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2016 - 09/2008
2	Rituximab (Mabthera)FDA Link 10/2015 - 06/2005
2	Glycoproteins (Glycoprotein)IBA 01/2015 - 06/2000
2	C-Reactive ProteinIBA 01/2015 - 08/2000
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2008 - 07/2008
2	Mitogen-Activated Protein KinasesIBA 09/2008 - 01/2008
2	Interleukin-8 (Interleukin 8)IBA 12/2006 - 04/2004
2	Thymidylate SynthaseIBA 03/2006 - 12/2003
2	InterleukinsIBA 02/2006 - 04/2004
2	Free RadicalsIBA 07/2004 - 02/2004
2	Antigen-Antibody Complex (Immune Complex)IBA 04/2004 - 04/2001
2	Triglycerides (Triacylglycerol)IBA 02/2004 - 01/2001
2	choto-sanIBA 03/2002 - 01/2001
2	VimentinIBA 05/2001 - 10/2000
2	AcidsIBA 01/2001 - 01/2001
2	LipidsIBA 01/2001 - 06/2000
2	oxidized low density lipoproteinIBA 01/2001 - 11/2000
2	Soybean Proteins (Soy Protein)IBA 01/2001 - 11/2000
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 06/2018
1	MacrolidesIBA 06/2018
1	Surface-Active Agents (Surfactants)IBA 01/2017
1	Doxycycline (Periostat)FDA LinkGeneric 01/2017
1	Urethane (Ethyl Carbamate)IBA 01/2017
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2016
1	Bone Marrow Stromal Antigen 2IBA 03/2016
1	Tyrosine Kinase InhibitorsIBA 01/2016
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2016

Therapy/Procedure

11	Therapeutics 01/2017 - 06/2000
3	Splenectomy 06/2018 - 10/2000
3	Liver Transplantation 06/2018 - 10/2015
3	Nephrectomy 07/2002 - 02/2000
2	Stem Cell Transplantation 10/2010 - 11/2008
2	Intravenous Infusions 10/2009 - 03/2000
2	Colonoscopes 12/2006 - 01/2001
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 06/2005 - 01/2000
2	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 03/2004 - 07/2000
1	Maintenance Chemotherapy 01/2017
1	Kidney Transplantation 04/2016